The present invention relates to a process for the production of heparin derivatives having an average molecular weight of from about 4.6 to about 6.9 kDa and an anti factor Xa activity of less than about 10 lU/mg comprising the steps of oxidation of unfractionated heparin depolymerisation and reduction of resulting terminal groups.